Skip to content

ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry

ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04301258
Enrollment
48
Registered
2020-03-10
Start date
2020-01-06
Completion date
2023-09-14
Last updated
2025-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cartilage Damage, Cartilage Injury

Keywords

Cartilage, Cartilage Injury, Cartilage Repair, Cartilage Damage, Cartilage Lesion, Cartilage Defect

Brief summary

The primary objective of this registry is to obtain long-term outcomes on ProChondrix CR in cartilage repair procedures of the knee, ankle, foot and hip.

Detailed description

This multi-center, observational registry will be used to evaluate the effectiveness of ProChondrix CR in patients who undergo treatment for an articular cartilage defect in the knee, ankle, foot or hip. This registry will be performed at up to 30 clinical sites across the United States. Patient follow-up will occur following an articular cartilage repair procedure in which the patient receives ProChondrix CR. During this follow-up period, each patient will be evaluated at least four (4) times at: 3, 6, 12 and 24 months after surgical intervention and will continue annually for as long as patients are willing to fill out questionnaires and outcomes assessments up to 10 years post operatively.

Interventions

OTHERArticular cartilage repair

Patient reported outcomes will be collected on patients who have had a cartilage repair procedure using ProChondrix CR in the knee, hip, foot or ankle.

Sponsors

AlloSource
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed by physician to have a cartilage defect in the knee, ankle, foot or hip that requires surgical intervention; * Will be having, or has had, a cartilage repair procedure using ProChondrix CR; * Has the ability to understand the requirements of the registry, to provide written informed consent and to comply with the registry protocol;

Exclusion criteria

• Is a ward of the state, prisoner, or transient.

Design outcomes

Primary

MeasureTime frameDescription
Long-Term Outcomes of ProChondrix CR10 Years Post-OperativeObtain long-term results on patients who have undergone an articular cartilage repair procedure using ProChondrix CR, as assessed by patient reported outcomes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026